Navigation path

Pharmaceuticals - Union Register


Register of not active orphan medicinal products


Product information

Allogeneic ex vivo expanded umbilical cord blood cells

EU orphan designation number: EU/3/09/649
Active ingredient: Allogeneic ex vivo expanded umbilical cord blood cells
Indication: Treatment of Hodgkin lymphoma
Sponsor: Regulatory Resources Group Ltd
Innovation House, Albany Park, Camberley, Surrey GU16 7PL, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/07/2009 Orphan designation EMEA/OD/034/09 (2009)6040 of 24/07/2009
15/09/2011 Change of name and/or address of sponsor EMEA/OD/034/09
29/07/2013 Transfer of orphan designation EMEA/OD/034/09/T/01 (2013)4956 of 25/07/2013
18/02/2015 Removal of orphan designation from Community Register